Deutsche Bank Ag\ Acadia Pharmaceuticals Inc Transaction History
Deutsche Bank Ag\
- $245 Billion
- Q1 2025
A detailed history of Deutsche Bank Ag\ transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 760,594 shares of ACAD stock, worth $16.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
760,594
Previous 1,042,447
27.04%
Holding current value
$16.6 Million
Previous $19.1 Million
33.96%
% of portfolio
0.01%
Previous 0.01%
Shares
34 transactions
Others Institutions Holding ACAD
# of Institutions
351Shares Held
165MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$937 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$332 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$264 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$187 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$153 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.54B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...